Streetbeat News

Products Services

ATNM

Actinium Pharmaceuticals has initiated a strategic program to enhance the production of the medical isotope Actinium-225, utilizing its unique cyclotron-based method. This move aims to capitalize on the growing demand for Actinium-225 in medical treatments.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:46 am

APCX

AppTech Corp. (APCX) has entered into an agreement to offer its FinZeo platform services to a credit union that operates over 2,000 locations. This partnership aims to enhance the credit union's service offerings.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:44 am

CYN

Cyngn has released the first footage of its AI-powered autonomous Motrec Tugger, showcasing the company's advancements in autonomous vehicle technology. This development could signal a significant step forward for Cyngn in the autonomous vehicle market.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:33 am

AUVI

Applied UV, through its SteriLumen subsidiary, has filed a patent application for a 'Disinfection System Comprised of Multiple Wavelengths Each Controlled Optimally'. This innovation could potentially enhance the effectiveness of disinfection systems by utilizing a combination of wavelengths, each optimized for specific disinfection purposes.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:33 am

SOGP

Sound Group Inc. (NASDAQ:SOGP), a global audio-centric social and entertainment company, announced an upgrade to one of its AI-powered applications, introducing voice technology and the latest AI models.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:31 am

PMN

ProMIS Neurosciences has received patent approvals from the European Patent Office, Japanese Patent Office, and IP Australia for PMN310, a novel monoclonal antibody for Alzheimer's disease treatment. These patents cover the composition of matter and method of use for PMN310, which targets toxic oligomers of amyloid-beta, a key factor in Alzheimer's disease progression.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:19 am

CLDI

Calidi Biotherapeutics and City of Hope have received a $5.3M grant from the California Institute for Regenerative Medicine to advance their CLD-101 (Neuronova) treatment for ovarian cancer. This funding aims to support the development and potential commercialization of CLD-101, a promising therapeutic option for ovarian cancer patients.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:18 am

SILV

SilverCrest reported sales of 58,200 ounces of gold and 5.62 million ounces of silver, totaling 10.25 million ounces of silver equivalent (AgEq) in Q4. This indicates a significant production and sales achievement for the company.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:18 am

BRKR

Bruker Corporation announced advancements in its CCS-Enabled 4D-Proteomics TimsTOF solutions for immunopeptidomes and glycoproteomics at the US Human Proteome Organization Congress 2024. These developments are expected to enhance research capabilities in proteomics.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:17 am

CDT

Conduit Pharmaceuticals announced the opening of a new prime laboratory space in Cambridge, UK, marking a significant expansion for the company.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:16 am